Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

22 results
Display

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients

Mitsuhashi A, Habu Y, Kobayashi , Kawarai Y, Ishikawa H, Usui H, Shozu M

OBJECTIVE: The present study investigated long-term outcomes of medroxyprogesterone acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC), and post-treatment conception. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience

Wang Y, Nisenblat , Tao L, Zhang X, Li H, Ma C

OBJECTIVE: To evaluate the effectiveness of oral contraceptive pill (OCP) as therapy for endometrial hyperplasia (EH) without atypia in reproductive-aged women compared with oral progestin. METHODS: A retrospective cohort study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D

OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A simultaneous occurrence of feline mammary carcinoma and uterine cystic endometrial hyperplasia in a cat

Yoo JH, Kim O

At the time of visiting, the cat was 6-year-old female Siamese cat. The mammary mass was solid and firm and measured 2 × 5 cm2 in greatest diameter. The uterus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women

Kim MJ, Kim JJ, Kim SM

OBJECTIVE: The aim of our study is to determine clinical factors and sonographic findings associated with endometrial hyperplasia or cancer (EH+) in premenopausal and perimenopausal women. METHODS: A total of 14,340...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neutrophil-lymphocyte and platelet-lymphocyte ratios in endometrial hyperplasia

Cakmak B, Gulucu S, Aliyev N, Ozsoy Z, Nacar M, Koseoglu D

OBJECTIVE: The purpose of present study was to evaluate association between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) and endometrial hyperplasia (EH). METHODS: One hundred and ten women with abnormal uterine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia

Han SJ, Kim MK

OBJECTIVE: Women with Lynch syndrome have an increased risk of developing colorectal and gynecologic malignancies such as endometrial cancer. Complex hyperplasia has about a 30% risk of developing into endometrial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of cyclooxygenase-2 and p53 expression in normal endometrium, endometrial hyperplasia and endometrial cancer

Yoo SW, Kim OK, Song JY, Hong SC, Lee NW, Lee KW

  • KMID: 2083894
  • Korean J Gynecol Oncol.
  • 2006 Sep;17(3):234-240.
OBJECTIVE: The purpose of this study is to compare the expression rate of cyclooxygenase-2 (COX-2), p53 in endometrial hyperplasia, endometrial cancer and normal endometrium and to correlate COX-2 with the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of E-cadherin and Catenin (alpha-, beta-catenin) in Endometrial Cancer and Atypical Complex Endometrial Hyperplasia

Yang YJ, Lee HJ, Lee KH, Lee YY, Jang ED, Lee JW, Namkoong S, Park TC

  • KMID: 1594567
  • Korean J Obstet Gynecol.
  • 2005 Jun;48(6):1456-1465.
OBJECTIVE: To evaluate the correlation of the expression of E-cadherin, alpha-catenin, beta-catenin and the clinicopathological features in endometrial cancer (EC) and atypical complex endometrial hyperplasia (ACEH). METHODS: Immunohistochemical (IHC) staining...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and Pathologic Study of Abnormal Uterine Bleeding in Premenopausal Women-To Evaluate the Prognostic Variables of Endometrial Hyperplasia

Ko JK, Choi H, Kang WS, Kim MH, Park KH, Lee CM, Cho YK, Kim BL, Lee HK

  • KMID: 2272233
  • Korean J Obstet Gynecol.
  • 2004 Jan;47(1):139-145.
OBJECTIVE: We performed this study to understand correlation between clinical aspects and pathological findings of abnormal uterine bleeding (AUB) and to evaluate the prognostic variables of endometrial hyperplasia. METHODS: We reviewed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of CD44 Variant 6 (V6) in endometrial cancer, endometrial hyperplasia, and normal endometrium

Song JY, Park HT, Lee NW, Kim YT, Kim IS, Lee KW

  • KMID: 2076670
  • Korean J Obstet Gynecol.
  • 2002 Sep;45(9):1472-1477.
OBJECTIVE: To compare the expression of CD44 V6 in normal endometrium, endometrial hyperplasia, and endometrial cancer and to evaluate CD44 variant 6 for prognostic marker. METHODS: Seventy six endometrial samples...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overexpression of Hepatocyte Growth Factor and c-Met as well as Angiogenesis in Endometrial Hyperplasia and Adenocarcinoma

Kang GJ, Sin BS, Jang SK, Yoon MS, Lee CH

  • KMID: 2270098
  • Korean J Obstet Gynecol.
  • 2001 Feb;44(2):355-363.
OBJECTIVE: This study was carried out to evaluate the clinicopathologic significance of hepatocyte growth factor (HGF) and c-met expression as well as tumor angiogenesis in endometrial hyperplasia and adenocarcinoma. METHOD: By...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bcl - 2 and bax expression in endometrial hyperplasia and adenocarcinoma

Lee BS, Hong SO, Yang WI, Lee JS, Cha DH, Cho YS, Kim JY, Park KH, Cho DJ, Song CH

  • KMID: 2262081
  • Korean J Obstet Gynecol.
  • 2000 Sep;43(9):1574-1580.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytologic Features of Endometrial Hyperplasia: Comparison with Normal Endometrium and Endometrial Adenocarcinoma

Hong SR, Seon MI, Kim YJ, Chun YK, Kim HS, Kim HS

  • KMID: 2013338
  • Korean J Cytopathol.
  • 2000 Jun;11(1):1-10.
The purpose of this study is to describe the cellular characteristics of endometrial hyperplasia without/with atypia in cervical smears. These cellular features were compared with those of normal endometrium and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
K-ras and p53 gene mutation in endometrial hyperplasia and adenocarcinoma

Kim HO, Lee JH, Lee IW, Han SA, Park MJ, Cho HD, Kim IS, Kim CH

  • KMID: 2261537
  • Korean J Obstet Gynecol.
  • 1999 Oct;42(10):2192-2198.
Endometrial adenocarcinoma is the third common malignancy of female genital tract and categorized as estrogen-dependent tumor (type I) or not (type II). Type II endometrial adenocarcinoma more frequently occurs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of endometrial hyperplasia with Medroxyprogesterone acetate(MPA)

Kim SM, Shin KS, Kim YH, Choi HS, Byun JS

  • KMID: 2269737
  • Korean J Obstet Gynecol.
  • 1999 Aug;42(8):1655-1660.
OBJECTIVE: To investigate the response of hyperplastic endometrium to Medroxyprogesterone acetate according to the histologic types such as simple typical, complex typical and atypical hyperplasia. METHODS: A total of 79...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bcl-2 Expression in Endometrial Hyperplasia and Carcinoma

Kim JH, Koh CW, Huh JY, Kim BH, Kong HS, Na JH, Kim YN, Kim YT, Nam JH

  • KMID: 2175315
  • J Korean Cancer Assoc.
  • 1998 Dec;30(6):1207-1218.
PURPOSE: To speculate the role of bcl-2 protooncogene in endometrial carcinogenesis by determination of the expression of bcl-2 in endometrial hyperplasia and carcinoma. MATERIALS AND METHODS: We studied bcl-2 expression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study of p53 Overexpression in Endometrial Disorder, Endometrial Hyperplasia, and Endometrial Carcinoma

Min YS, Kim WG, Lee KB, Kim KT

  • KMID: 1890513
  • Korean J Gynecol Oncol Colposc.
  • 1998 Jun;9(2):144-150.
Endometrial carcinoma is the most common female genital organ malignancy in western countries and the incidence is increasing in Korea. Endometrial carcinoma frequently develops under the condition of excessive prolonged...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overexpression of p53 Protein in Endometrial Hyperplasia and Adenocarcinoma

Kim YS, Lee MS, Lim SC, Sohn JS, Suh CH

  • KMID: 1979418
  • Korean J Pathol.
  • 1997 Jul;31(7):655-661.
Proliferations of the endometrial glands form a continuum from focal glandular crowding through simple hyperplasia, complex hyperplasia and atypical hyperplasia to frank adenocarcinoma. But objective criteria to distinguish these...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of p53 Gene in the Endometrial Hyperplasia and Andenocarcinoma

Nam JH, Kim HS, Park CS

  • KMID: 2275056
  • Chonnam Med J.
  • 1996 Dec;32(2):107-120.
We examined the expression of the p53 gene in eight cases of simple endometrial hyperplasia, four cases of complex hyperplasia, six cases of atypical hyperplasia and twenty four cases of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr